Aurora Cannabis to Host Q3 Fiscal 2025 Investor Call

Ticker: ACB · Form: 6-K · Filed: 2025-01-24T00:00:00.000Z

Sentiment: neutral

Topics: investor-relations, earnings-call, announcement

Related Tickers: ACB

TL;DR

Aurora Cannabis (ACB) is hosting its Q3 fiscal '25 earnings call on Jan 22, 2025. Expect financial results.

AI Summary

Aurora Cannabis Inc. announced on January 22, 2025, that it will host its third quarter fiscal 2025 investor conference call. The call will discuss the company's financial and operational results for the period ending December 31, 2024. Miguel Martin, CEO, will present the findings.

Why It Matters

This announcement signals the upcoming release of Aurora Cannabis's quarterly financial performance, which will provide investors with insights into the company's operational health and market position.

Risk Assessment

Risk Level: low — This filing is a routine announcement of an upcoming investor call and does not contain new material financial information or significant corporate events.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to report a news release dated January 22, 2025, announcing that Aurora Cannabis Inc. will host its third quarter fiscal 2025 investor conference call.

When is the investor conference call scheduled to take place?

The news release announcing the investor conference call was dated January 22, 2025. The filing itself was made on January 24, 2025.

Who is the Chief Executive Officer of Aurora Cannabis Inc. and who signed the report?

Miguel Martin is the Chief Executive Officer of Aurora Cannabis Inc. and he signed the report on behalf of the company.

What are the stock exchange listings for Aurora Cannabis Inc.?

Aurora Cannabis Inc. is listed on NASDAQ and TSX.

What fiscal period will the upcoming investor conference call cover?

The upcoming investor conference call will cover the third quarter of fiscal 2025.

From the Filing

0001279569-25-000076.txt : 20250124 0001279569-25-000076.hdr.sgml : 20250124 20250124134137 ACCESSION NUMBER: 0001279569-25-000076 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250122 FILED AS OF DATE: 20250124 DATE AS OF CHANGE: 20250124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 25553373 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated January 22, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: January 22, 2025 EX-99.1 2 ex991.htm NEWS RELEASE DATED JANUARY 22, 2025 Exhibit 99.1 Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 5, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events". About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the

View on Read The Filing